My Pitch: "It's the pipeline."

My Pitch: "http://barchart.com/charts/stocks/IMGN 10.23 0.07 (+0.69%)Fri, Sep 23rd, 2011 VOL@NEWS ALERT CHART "

My Pitch: "Sold - Lost money - in Phase 3 trial now - might make it - might not"

My Pitch: "Antibody drug conjugate Kadcyla is approved to treat HER-2 metastatic breast cancer in patients
that have received prior treatment with Herceptin and a taxane chemotherapy.
Thus far the combination of ImmunoGen's ADC technology and Roche's Herceptin appears to be
working."

My Pitch: "Doesn't need a 'pitch'"